Portfolio company
Mnemo Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops cell therapies and an epigenetic antigen discovery platform to treat solid tumours and blood cancers for healthcare providers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Alphina Therapeutics
This biotechnology company develops antibody-drug conjugates with novel payloads to treat solid tumours for healthcare providers and cancer patients.
Neogene Therapeutics
This biotechnology company develops engineered T cell receptor therapies targeting neoantigens in solid cancers for patients with oncology needs.
Infinitopes
This biotechnology company develops precision therapeutic cancer vaccines and antigen discovery platforms for healthcare providers and patients with solid tumours.
Revealis Biotherapeutics
This company develops therapeutic cancer vaccines targeting immune-escaped and immunotherapy-resistant tumours for healthcare providers and patients.
Siren Biotechnology
The company develops adeno-associated virus immuno-gene therapies to treat solid tumour cancers for healthcare providers and patients.
Mersana Therapeutics
This company develops antibody-drug conjugates to treat various cancers for healthcare providers and patients within the oncology sector.
Caedo Oncology
This company develops monoclonal antibody therapeutics that induce programmed cell death in cancer cells for healthcare providers and patients.
Mosaic Therapeutics
The company develops targeted oncology drug combinations and biomarker-defined therapies for cancer patients and healthcare providers.
